JEK(603205.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
JEK
603205.SH
Jianerkang Medical Co.,Ltd. engages in the production, and sales of disposable medical devices, medical dressings, and disinfection and hygiene products in China and internationally. The company offers surgical supplies, including disposable surgical gown, sterile oral bag, sterile birth pack, sterile cesarean delivery pack, sterile ophthalmic bag, sterile orthopedic bag, and sterile universal surgical bags; single-use sterile interventional packs; medical surgical film; surgical towels; lap sponge; sterile protective cover; needle counter; surgical scrub brush; medical paper towel; and prepare leather bag. It also provides sanitary wipes/chrysanthemum wipes; wet wipes/wet toilet paper; hair cleansing; alcohol pads and cotton ball; alcohol and PVP swabsticks; PVP cotton ball; chlorhexidine gluconate cotton swabs; alcohol and chlorhexidine gluconate swabs; alcohol disinfectant; iodophor disinfectant; quaternary ammonium salt disinfectant; benzalkonium chloride disinfectant; hand sanitizing gel; baby hand and mouth wipes; hygienic wipes/private care for women; glasses wipe; cotton soft towel; and cotton piece.
353.51 B
603205.SHMarket value -Rank by Market Cap -/-

Financial Score

22/01/2026 Update
B
Health Care SuppliesIndustry
Industry Ranking11/41
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE8.37%B
    • Profit Margin10.44%B
    • Gross Margin27.23%C
  • Growth ScoreD
    • Revenue YoY-10.58%D
    • Net Profit YoY-22.78%D
    • Total Assets YoY38.40%A
    • Net Assets YoY44.85%A
  • Cash ScoreC
    • Cash Flow Margin957.82%B
    • OCF YoY-10.58%D
  • Operating ScoreB
    • Turnover0.7B
  • Debt ScoreA
    • Gearing Ratio11.53%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    JEK: Net profit in the first half of 2025 was 48.1472 million yuan, a year-on-year decrease of 21.00%

    JEK announced that its operating revenue in the first half of 2025 was 466 million yuan, a year-on-year decrease of 7.60%. Net profit was 48.1472 million yuan, a year-on-year decrease of 21.00%

    Zhitong·
    SH
    603205
    +0.67%
    Zhitong·
    SH
    603205
    +0.67%

    JEK: The company does not have any significant matters that should be disclosed but have not been disclosed

    JEK announced that due to the cumulative deviation of the daily closing price increase of the stock reaching 20% over three consecutive trading days from April 22 to 24, 2025, it constitutes an abnormal fluctuation. After self-examination and confirmation with the controlling shareholder, the company has no significant matters that should be disclosed but have not been disclosed, its production and operation activities are normal, and no media reports or market rumors that have a significant impact on the stock trading price have been found

    Zhitong·
    SH
    603205
    +0.67%
    Zhitong·
    SH
    603205
    +0.67%

    Jianerkang Medical released its 2024 annual performance, with a net profit attributable to the parent company of 120 million yuan, a year-on-year decrease of 2.69%

    Jianerkang Medical released its 2024 annual report, with operating revenue of 1.046 billion yuan, a year-on-year increase of 1.18%; net profit attributable to the parent company of 120 million yuan, a year-on-year decrease of 2.69%; net profit excluding non-recurring gains and losses of 115 million yuan, a year-on-year decrease of 4.41%; basic earnings per share of 1.27 yuan/share. The company plans to distribute a cash dividend of 3.51 yuan (including tax) for every 10 shares and intends to convert 3 shares for every 10 shares to all shareholders from the capital reserve

    Zhitong·
    SH
    603205
    +0.67%
    Zhitong·
    SH
    603205
    +0.67%

    Jianerkang Medical released its first-quarter performance, with a net profit attributable to the parent company of 28.8051 million yuan, a year-on-year increase of 15.42%

    Jianerkang Medical released its Q1 2025 earnings report, with operating revenue of 241 million yuan, a year-on-year increase of 13.69%; net profit attributable to the parent company of 28.8051 million yuan, a year-on-year increase of 15.42%; net profit after deducting non-recurring gains and losses of 27.7976 million yuan, a year-on-year increase of 14.58%; basic earnings per share of 0.24 yuan/share

    Zhitong·
    SH
    603205
    +0.67%
    Zhitong·
    SH
    603205
    +0.67%
    © 2026 Longbridge｜Disclaimer